Google Scholar Profile

Bio Summary: Dr. Geeta Rao is an accomplished Assistant Professor in the Department of Pathology at the University of Oklahoma Health Sciences Center (OUHSC) in Oklahoma City, OK. With a Ph.D. in Life Science from SGPGIMS Lucknow, India, she has established herself as a leading researcher in molecular biology, cell signaling, and cancer biology. Dr. Rao’s dedication to advancing scientific knowledge is evident in her prolific research contributions, leadership in academic positions, and numerous honors and awards.

Education:

Ph.D. in Life Science, SGPGIMS Lucknow, India (2006-2012)

M.Sc. in Biotechnology, V.B.S. P. University, Jaunpur, UP, India (2002-2004)

B.Sc., V.B.S. P. University, Jaunpur, UP, India (1999-2002)

Research Focus:

Dr. Rao’s research centers around understanding the metabolic reprogramming that occurs in cells under different physiological and pathological conditions. She investigates the intricate interplay between metabolic programming and nuclear reprogramming, particularly focusing on cancer and endothelial biology. Her work aims to uncover therapeutic concepts and novel cancer treatments by deciphering the complexities of cellular microenvironments and their impact on vascular growth.

Professional Journey:

Assistant Professor, Dept. of Pathology, OUHSC, OK (2023-present)

Assistant Professor (Research), Dept. of Pathology, OUHSC, OK (2021-2023)

Postdoctoral Fellow, Dept. of Pathology, OUHSC, OK (2017-2021)

Postdoctoral Fellow, College of Pharmacy, OUHSC, OK (2014-2016)

Postdoctoral Fellow, BHU, Varanasi, India (2013-2014)

Senior Research Fellow, CDRI, Lucknow, UP, India (2012-2013)

Junior Research Fellow, SGPGIMS, Lucknow UP, India (2006-2008)

Research Assistant, IGIB, New Delhi, India (2004-2006)

Honors & Awards:

John B. Bruce Scholarship Award (2016)

UGC-DS Kothari postdoctoral fellowship recipient

Senior Research Fellowship from CSIR, India (2008-2011)

Junior Research Fellowship from CSIR, India (2006-2008)

Gold Medal in M.Sc. Biotechnology, V.B.S.P. University Jaunpur, UP, India

Publications Top Noted & Contributions:

Dr. Rao’s extensive contributions are evident in her 25+ peer-reviewed scientific journals, covering a range of impactful publications in renowned journals such as ASC Nano, EMBO Reports, Materials Today, The FASEB Journal, and Science Advances. Her research highlights include investigations into the role of cystathionine beta-synthase (CBS), MICU1, and gold nanoparticles in cancer progression and drug resistance.

Title: Maternal footprints of southeast Asians in North India
Authors: K Thangaraj, G Chaubey, T Kivisild, D Selvi Rani, VK Singh, T Ismail, …
Journal: Human heredity
Volume: 66 (1)
Pages: 1-9
Year: 2008
Citations: 57

Title: Gold Nanoparticles Disrupt Tumor Microenvironment – Endothelial Cell Cross Talk To Inhibit Angiogenic Phenotypes in Vitro
Authors: Y Zhang, X Xiong, Y Huai, A Dey, MN Hossen, RV Roy, CK Elechalawar, …
Journal: Bioconjugate chemistry
Volume: 30 (6)
Pages: 1724-1733
Year: 2019
Citations: 43

Title: Effect of hypothyroxinemia on thyroid hormone responsiveness and action during rat postnatal neocortical development
Authors: S Babu, RA Sinha, V Mohan, G Rao, A Pal, A Pathak, M Singh, …
Journal: Experimental neurology
Volume: 228 (1)
Pages: 91-98
Year: 2011
Citations: 43

Title: Gold nanoparticle transforms activated cancer-associated fibroblasts to quiescence
Authors: MN Hossen, G Rao, A Dey, JD Robertson, R Bhattacharya, P Mukherjee
Journal: ACS applied materials & interfaces
Volume: 11 (29)
Pages: 26060-26068
Year: 2019
Citations: 40

Title: Cystathionine β-synthase regulates mitochondrial morphogenesis in ovarian cancer
Authors: PK Chakraborty, B Murphy, SB Mustafi, A Dey, X Xiong, G Rao, S Naz, …
Journal: The FASEB Journal
Volume: 32 (8)
Pages: 4145

Author Metrics:

Published over 25 peer-reviewed scientific journals with 13 first-author publications.

Notable contributions in journals such as ACS Nano, EMBO Reports, and The FASEB Journal.

Regularly cited and recognized for significant contributions in the field of cancer and endothelial biology.

Dr. Geeta Rao’s scholarly impact, measured by citations, h-index, and i10-index. The “Since 2019” column represents metrics accumulated from 2019 until the present, while the “Overall” column includes the entire span of Dr. Rao’s academic career.

These metrics provide insights into the influence and visibility of Dr. Rao’s research within the academic community. The h-index indicates the number of papers (h) that have received at least h citations, offering a measure of both productivity and impact. The i10-index represents the number of publications with at least 10 citations, reflecting the author’s broader impact. Dr. Rao’s consistent contributions have led to significant academic recognition and scholarly influence.

Research Timeline:

Doctoral Research (2006-2012): Investigated molecular aspects of iodine deficiency during cerebellar development in rats at SGPGIMS, India.

Postdoctoral Research (2013-2021): Explored roles of micro-RNA-195, CBS, UBAP2, and gold nanoparticles in various cancers, including ovarian and pancreatic cancer, at OUHSC.

Assistant Professor (2023-present): Leading research initiatives in the Department of Pathology at OUHSC, continuing to delve into metabolic reprogramming in cancer.

Dr. Geeta Rao’s academic journey showcases her commitment to advancing scientific knowledge, and her research has significant implications for understanding and treating cancer and related pathologies.

• Orcid Profile
• Scopus Profle

Bio Summary:

Dr. Moorthy Palanimuthu Ponnusamy is an accomplished scientist and Associate Professor (Tenure) at the University of Nebraska Medical Center (UNMC). He serves as the Co-Director of the Masters Program in Biochemistry and Molecular Biology (BMB) at UNMC, contributing significantly to the academic and research endeavors in the field of cancer biology. Dr. Ponnusamy is also associated with the Department of Pathology and Microbiology at UNMC as an Associate Professor (Courtesy).

Education:

Ph.D. (Stem Cell Biology – Biochemistry), University of Madras, India, 2001-2005

M.Sc. (Biochemistry), Bharathidasan University, India, 1999-2001

B.Sc. (Biochemistry), Bharathidasan University, India, 1996-1999

Postdoctoral Fellow (Cancer Biology), University of Nebraska Medical Center, 2006-2009

Research Focus:

Dr. Ponnusamy’s research primarily revolves around cancer biology, with a specific focus on pancreatic cancer. His work explores the molecular mechanisms underlying metastatic dissemination, pancreatic organ-specific metastasis, and the role of specific genes and factors in cancer stem cells. He is actively involved in various research projects funded by prestigious organizations, including the National Institutes of Health (NIH) and the Fred and Pamela Buffet Cancer Center.

Professional Journey:

Dr. Ponnusamy’s professional journey at UNMC has been extensive, starting as a Postdoctoral Research Fellow in 2006 and progressing through various roles, including Instructor, Assistant Professor, and ultimately achieving the rank of Associate Professor with tenure. He has contributed significantly to the academic community, holding leadership positions such as the Director of the Masters Program and serving on various committees related to curriculum, seminars, and graduate education.

Honors & Awards:

Dr. Ponnusamy has received numerous accolades throughout his career, including the Distinguished Scientist Award (2021) and the Joseph P. Gilmore Distinguished New Investigator Award (2018) from UNMC. His commitment to teaching, service, and research collaboration was recognized with the Academic Variable Compensation in 2016. Notably, he was awarded the Best Postdoctoral Scholar of the Year (2009-2010) during his early years at UNMC.

Publications Top Noted & Contributions:

Dr. Ponnusamy has made substantial contributions to scientific literature, with a focus on cancer-related research. His publications contribute valuable insights to the understanding of pancreatic cancer, drug resistance, and cancer stem cells. As an active member of editorial boards and review panels, he plays a crucial role in shaping the scientific discourse.

Blocking c-MET/ERBB1 Axis Prevents Brain Metastasis in ERBB2+ Breast Cancer

• Published in Cancers, October 2020
• DOI: 10.3390/cancers12102838
• Source: Multidisciplinary Digital Publishing Institute

hPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells

• Published in Oncotarget, 2017
• DOI: 10.18632/oncotarget.14775
• Source: Moorthy Palanimuthu Ponnusamy via Scopus – Elsevier

MUC16 regulates TSPYL5 for lung cancer cell growth and chemoresistance by suppressing p53

• Published in Clinical Cancer Research, 2017
• DOI: 10.1158/1078-0432.CCR-16-2530
• Source: Moorthy Palanimuthu Ponnusamy via Scopus – Elsevier

Hypoxia-induced oxidative stress promotes MUC4 degradation via autophagy to enhance pancreatic cancer cells survival

• Published in Oncogene, 2016
• DOI: 10.1038/onc.2016.119
• Source: Moorthy Palanimuthu Ponnusamy via Scopus – Elsevier

Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: Augmented aggressiveness and aberrant ErbB family glycosylation

• Published in: British Journal of Cancer, 2016
• DOI: 10.1038/bjc.2016.116
• EID: 2-s2.0-84969194701
• Source: Moorthy Palanimuthu Ponnusamy via Scopus – Elsevier

Author Metrics:

While specific author metrics are not provided, Dr. Ponnusamy’s contributions are reflected in the recognition he has received, the impact of his research, and his role in various editorial positions. These metrics collectively underscore his influence in the scientific community.

Research Timeline:

Postdoctoral Research Fellow, University of Nebraska Medical Center (2006-2009)

Instructor, Assistant Professor (Tenure-Track), and Associate Professor (Tenure), UNMC (2010-Present)

Co-Director, Masters Program, Department of BMB, UNMC (2022-Present)

Active involvement in extramural research projects, including those funded by NIH and the Fred and Pamela Buffet Cancer Center.

Dr. Moorthy Palanimuthu Ponnusamy’s professional journey showcases a dedication to advancing scientific knowledge in cancer biology, mentoring the next generation of researchers, and actively contributing to the academic community.